Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-589207
Filing Date
2016-05-13
Accepted
2016-05-12 20:01:03
Documents
13
Period of Report
2016-05-12

Document Format Files

Seq Description Document Type Size
1 6-K d189137d6k.htm 6-K 10457
2 EX-99.1 d189137dex991.htm EX-99.1 47755
3 GRAPHIC g189137ex991pg01a.jpg GRAPHIC 42560
4 GRAPHIC g189137ex991pg01b.jpg GRAPHIC 23300
5 GRAPHIC g189137ex991pg01c.jpg GRAPHIC 19276
6 GRAPHIC g189137ex991pg02a.jpg GRAPHIC 11517
7 GRAPHIC g189137ex991pg02b.jpg GRAPHIC 80873
8 GRAPHIC g189137ex991pg03a.jpg GRAPHIC 3609
9 GRAPHIC g189137ex991pg03b.jpg GRAPHIC 74551
10 GRAPHIC g189137ex991pg04a.jpg GRAPHIC 12192
11 GRAPHIC g189137ex991pg04b.jpg GRAPHIC 121985
12 GRAPHIC g189137ex991pg05.jpg GRAPHIC 3257
13 GRAPHIC g189137ex991pg06.jpg GRAPHIC 11637
  Complete submission text file 0001193125-16-589207.txt   617563
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 161645526
SIC: 2834 Pharmaceutical Preparations